We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
+1.2%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$38.6B
AUM Growth
+$669M
Cap. Flow
+$1.61B
Cap. Flow %
4.18%
Top 10 Hldgs %
13.49%
Holding
2,814
New
394
Increased
941
Reduced
1,071
Closed
396

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$486M
2
PFE icon
Pfizer
PFE
+$433M
3
AAPL icon
Apple
AAPL
+$430M
4
TSLA icon
Tesla
TSLA
+$401M
5
ROKU icon
Roku
ROKU
+$374M

Sector Composition

Rank Sector Weight
1 Technology 24.02%
2 Healthcare 23.8%
3 Communication Services 9.19%
4 Financials 8.73%
5 Consumer Discretionary 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCEL
2351
NewcelX Ltd
NCEL
$18.8M
$68K ﹤0.01%
68
+41
+152% +$43.8K
PETV
2352
DELISTED
PetVivo Holdings, Inc. Common Stock
PETV
$67K ﹤0.01%
+24,900
New +$75.4K
RNWK
2353
DELISTED
RealNetworks Inc
RNWK
$64K ﹤0.01%
+40,500
New +$74.3K
TAIT
2354
DELISTED
Taitron Components
TAIT
$63K ﹤0.01%
+16,500
New +$73K
VIOT
2355
Viomi Technology
VIOT
$51.8M
$63K ﹤0.01%
+13,800
New +$77.7K
CLPS icon
2356
CLPS Inc
CLPS
$25.6M
$62K ﹤0.01%
21,600
-700
-3% -$2.46K
COCP icon
2357
Cocrystal Pharma
COCP
$11.3M
$60K ﹤0.01%
+4,792
New +$63.4K
TRVN
2358
DELISTED
Trevena, Inc.
TRVN
$60K ﹤0.01%
+78
New +$66.1K
TOVX icon
2359
Theriva Biologics
TOVX
$9.64M
$59K ﹤0.01%
513
+378
+280% +$47K
YTRA icon
2360
Yatra Online
YTRA
$52.7M
$58K ﹤0.01%
28,700
+600
+2% +$1.17K
CO
2361
DELISTED
Global Cord Blood Corporation
CO
$58K ﹤0.01%
+12,400
New +$60.8K
AEG icon
2362
Aegon
AEG
$14B
$57K ﹤0.01%
11,760
-121,505
-91% -$526K
RAVE icon
2363
RAVE Restaurant Group
RAVE
$44.8M
$57K ﹤0.01%
43,800
+6,300
+17% +$8.21K
GPL
2364
DELISTED
Great Panther Mining Limited
GPL
$57K ﹤0.01%
12,420
-35,470
-74% -$187K
CLRB icon
2365
Cellectar Biosciences
CLRB
$20.5M
$55K ﹤0.01%
199
-970
-83% -$296K
WVE icon
2366
Wave Life Sciences
WVE
$1.09B
$55K ﹤0.01%
11,300
-11,700
-51% -$70.9K
ACOR
2367
DELISTED
Acorda Therapeutics
ACOR
$55K ﹤0.01%
+600
New +$49.8K
SNT
2368
Senstar Technologies
SNT
$38M
$54K ﹤0.01%
+13,600
New +$66.8K
SQFT icon
2369
Presidio Property Trust
SQFT
$2.84M
$54K ﹤0.01%
+1,420
New +$56.4K
SYPR icon
2370
Sypris Solutions
SYPR
$42.8M
$54K ﹤0.01%
15,000
+600
+4% +$2.04K
PLM
2371
DELISTED
PolyMet Mining Corp.
PLM
$54K ﹤0.01%
17,610
-18,000
-51% -$60K
XMAX
2372
XMAX Inc
XMAX
$548M
$52K ﹤0.01%
+4,600
New +$60.5K
XPRO icon
2373
Expro Ltd
XPRO
$1.79B
$50K ﹤0.01%
2,850
-5,033
-64% -$85.4K
FNHC
2374
DELISTED
FedNat Holding Company Common Stock
FNHC
$48K ﹤0.01%
19,300
-400
-2% -$1.06K
BBAR icon
2375
BBVA Argentina
BBAR
$3.87B
$46K ﹤0.01%
+11,700
New +$41.4K

Similar funds

Two Sigma Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, Two Sigma Advisers held 2,814 positions worth $38.6B, up 1.8% from $37.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Two Sigma Advisers deployed $1.61B of net new capital in Q3 2021, opening 394 new positions and adding to 941 existing holdings. Its largest new stake was Danaher: 1,248,470 shares worth $337M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 20% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $486M trimmed.

  • Two Sigma Advisers's largest Q3 2021 buy was Danaher: 1,248,470 shares worth $337M.
  • Two Sigma Advisers added most to Microsoft in Q3 2021, an estimated $550M increase.
  • Two Sigma Advisers's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $486M.
  • Two Sigma Advisers fully exited Roku in Q3 2021, selling an estimated $374M.
  • Two Sigma Advisers's ten largest holdings make up 13% of its $38.6B portfolio in Q3 2021.
  • Two Sigma Advisers opened 394 new positions and closed 396 in Q3 2021.
  • Two Sigma Advisers's portfolio value rose 1.8% quarter-over-quarter to $38.6B.

Based on Two Sigma Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.